Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II
Authors:
- Nageswara Rao KonetiNKNageswara Rao Koneti
- Raghava Raju PenumatsaRPRaghava Raju Penumatsa
- Vasudevan KanchiVKVasudevan Kanchi
- Srinivas Kumar ArramrajSASrinivas Kumar Arramraj
- Jaishankar S.JSJaishankar S.
- Somaraju BhupathirajuSBSomaraju Bhupathiraju
- 2 February 2011
- journal article
- pediatric and-congenital-heart-disease
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 77 (2) , 252-259
Abstract
Objectives: To describe the technique and results of transcatheter closure of ventricular septal defects (VSDs) by a modified retrograde transarterial approach using the new Amplatzer Duct Occluder II (ADO II). Background: Transcatheter device closure of ventricular septal defects (VSDs) by antegrade method is well established, but a challenging procedure. We describe a retrograde technique that obviates the need for arteriovenous looping. Material and Methods: This is a prospective study from a single center. Between April 2009 and February 2010 13 children were identified for closure of various types of perimembranous and muscular VSDs using the ADO II device. All had met the criteria for surgical closure. Following left ventricular angiogram two were excluded as technically nonfeasible. The median age was 48 months (range 15–78). The median weight was 14 kg (range 7.5–20). The device was successfully deployed in the 11 selected children by the method described. The follow-up evaluation included chest roentgenogram, ECG, and echocardiogram on day 1, at 6 weeks, at 3, 6, and 12 months. Results: The immediate and follow up complete closure rates were 73 and 82%, respectively. The median fluoroscopic time was 14 min (range 8.2–45). There were no procedure related complications. All patients were doing well at median follow up of 10 months; none showing any conduction abnormality. Conclusion: Transcatheter retrograde device closure of selected cases of Ventricular Septal Defects using the Amplatzer Duct Occluder II is simple and appears safe in the short term and can be completed within a short fluoroscopic time.Keywords
This publication has 12 references indexed in Scilit:
- Experimental evaluation of a new articulated Amplatzer® ductal occluder device without fabricCatheterization and Cardiovascular Interventions, 2009
- Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusionCatheterization and Cardiovascular Interventions, 2009
- The Amplatzer® Membranous VSD Occluder and the vulnerability of the atrioventricular conduction systemCardiology in the Young, 2007
- Transcatheter Closure of Congenital Ventricular Septal Defect with Amplatzer Septal OccludersThe American Journal of Cardiology, 2005
- Transcatheter Device Closure of Congenital and Postoperative Residual Ventricular Septal DefectsCirculation, 2004
- Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluderJACC, 2004
- Initial human experience with the Amplatzer perimembranous ventricular septal occluder deviceCatheterization and Cardiovascular Interventions, 2003
- Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experienceCatheterization and Cardiovascular Interventions, 2002
- Mechanism of acquired right ventricular outflow tract obstruction in patients with ventricular septal defect: An angiocardiographic studyThe American Journal of Cardiology, 1982
- Natural history of ventricular septal defect. A study involving 790 cases.Circulation, 1977